Cyanotic Nephropathy - Implications of Medical and Surgical Management
International Journal of Drug Delivery Technology · 01.06.2026 · 16 (39s)
DOI: 10.25258/ijddt.16.39s.41 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, erschienen am 01.06.2026. Verfasst von Animesh Rathod und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
The progression of cyanotic nephropathy (CN) is due to complications that occur as a consequence of cyanotic congenital heart disease (CCHD). This type of nephropathy occurs in Type 2 Cardiorenal Syndrome (CRS).
Objective
In this research, we aim to examine the pathophysiology, diagnosis, symptoms, and prognosis for patients suffering from cyanotic nephropathy in relation to their medical or surgical treatment. Methodology: We used the methodology of systematic review and cross-sectional observational studies of pediatric or adult (aged between 2 to 18+ years) patients with CCHD who were admitted to NIMS Hospital of Jaipur, Rajasthan for a period of 18 months. All articles were collected using PubMed, Google Scholar, Cochrane library, and EMBASE databases.
Results
About 30-50% of adults with CCHD develop CN. Albuminuria (ACR >30 mg/g) was observed in 80.61% and high proteincreatinine ratio in 54.08% of the study participants. GFR
Zitieren
APA
Rathod, A., Chowdhury, U. K., Dubey, P., ., M., & ., R. (2026). Cyanotic Nephropathy - Implications of Medical and Surgical Management. International Journal of Drug Delivery Technology, 16(39s). https://doi.org/10.25258/ijddt.16.39s.41
Vancouver
Rathod A, Chowdhury UK, Dubey P, . M, . R. Cyanotic Nephropathy - Implications of Medical and Surgical Management. International Journal of Drug Delivery Technology. 2026;16(39s). doi:10.25258/ijddt.16.39s.41
BibTeX
@article{Rathod2026,
author = {Rathod, Animesh and Chowdhury, Ujjwal Kumar and Dubey, Priya and ., Masum and ., Rachna},
title = {Cyanotic Nephropathy - Implications of Medical and Surgical Management},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {39s},
doi = {10.25258/ijddt.16.39s.41}
}
EUVIMED